{
  "meta": {
    "title": "Pcos",
    "url": "https://brainandscalpel.vercel.app/pcos-064f3825.html",
    "scrapedAt": "2025-11-29T18:26:27.339Z"
  },
  "questions": [
    {
      "id": 12112,
      "choices": [
        {
          "id": 48412,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adrenal hyperplasiaI</span></p>"
        },
        {
          "id": 48413,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Idiopathic hirsutism</span></p>"
        },
        {
          "id": 48414,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic Ovarian Syndrome</span></p>"
        },
        {
          "id": 48415,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone secreting tumor</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old girl presents to the OPD with excess facial hair for 6 months and delayed menstrual cycles. On evaluation, levels of free testosterone are increased. An ultrasound reveals normal uterus and normal ovaries on USG. The most likely diagnosis is?</span></p>",
      "unique_key": "Q1275961",
      "question_audio": null,
      "question_video": null,
      "map_id": 18819,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. Polycystic Ovarian Syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovarian syndrome/ disease (PCOS/PCOD) is a disorder of chronically abnormal ovarian function (oligo/anovulation) and hyperandrogenism frequently associated with hyperinsulinemia and insulin resistance, resulting in menstrual irregularity, infertility, and hirsutism.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Rotterdam 2003 criteria is used to diagnose&nbsp; PCOS/PCOD:&nbsp;As per this criterion, at least 2 of 3 should be present:</strong></span></p><ol style=\"list-style-type:decimal;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Oligo/anovulation (causes oligomenorrhea, 20<sup> </sup>amenorrhea, and infertility)</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hyperandrogenism: Biochemical or clinical (increased serum androgens or acne, hirsutism)</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>12 or more than 12 follicle 2-9 mm in size present within 1 or both ovaries on USG and/or ovarian volume &gt; 10 mL (pearl necklace pattern).</strong></span></p></li></ol></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture9_0mgVKz8.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">USG appearance of polycystic ovaries</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">As the patient in the question satisfies first 2 criteria, she is a case of PCOS</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>let's consider the other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adrenal Hyperplasia</strong>: Adrenal hyperplasia, particularly congenital adrenal hyperplasia (CAH), can cause symptoms similar to PCOS, including hirsutism and menstrual irregularities, due to elevated androgens. However, it is usually diagnosed earlier in life and often has other associated adrenal hormone abnormalities.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Idiopathic Hirsutism</strong>: Idiopathic hirsutism refers to hirsutism (excess hair growth) in the absence of any identifiable hormonal imbalance or ovarian/adrenal gland disorder. Given the increased free testosterone levels in this patient, idiopathic hirsutism is less likely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Testosterone Secreting Tumor</strong>: While a testosterone-secreting tumor can cause increased androgen levels and symptoms like hirsutism, these tumors are rare. The more common presentation of such tumors would include rapid onset of symptoms and <strong>markedly elevated testosterone levels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic Ovarian Syndrome (PCOS) is the most likely diagnosis in a young woman presenting with hirsutism, menstrual irregularities, and elevated free testosterone levels. The diagnosis of PCOS is based on a combination of clinical, biochemical, and ultrasound findings, and it is important to consider this condition in women with such symptoms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 401, Speroff’s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12113,
      "choices": [
        {
          "id": 48416,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 48417,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">b, d, e</span></p>"
        },
        {
          "id": 48418,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">a, b, e</span></p>"
        },
        {
          "id": 48419,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c, d</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is correct about polycystic ovarian disease (PCOD)?</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Testosterone&gt; 2 ng/ml</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Infertility</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">High FSH/LH ratio</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fasting glucose/ insulin ratio &gt; 4.5</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic appearance on 1 or both ovaries on ultrasound</span></p></li></ol>",
      "unique_key": "Q9724069",
      "question_audio": null,
      "question_video": null,
      "map_id": 18820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. b, d, e</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOS includes chronic non ovulation, hyperandrogenism associated with normal or raised estradiol level (E2), raised LH0 &amp; low FSH/LH ratio.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Diagnosis:&nbsp;</strong>Diagnosis is based upon the presence of any two of the following three criteria (Rotterdam Criteria)</span></p><ol style=\"list-style-type:decimal;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Oligomenorrhoea/or anovulation (Delayed cycles and infertility)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hyperandrogenism (Clinical &amp;/or biochemical)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovaries (Ultrasound finding of 1 OR both ovaries)</span></p></li></ol></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">On investigations,&nbsp;</span></p><ul style=\"list-style-type:circle;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">LH: FSH ratio is increased (3:1) i.e. LH is more than FSH</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Increase free testosterone levels</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Increase DHEAS</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fasting glucose: insulin ratio &lt; 4.5</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sex hormone binding globulin decreases</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Possible late sequelae of PCOD are:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Risk of developing diabetes mellitus (15%) due to insulin resistance</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Risk of developing endometrial carcinoma due to elevated level of estrogen.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Risk of hypertension &amp; cardiovascular disease due w abnormal lipid profile (dyslipidaemia)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. A.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Testosterone &gt; 2 ng/ml</strong>: Elevated testosterone levels are a hallmark of PCOS, reflecting the condition's hyperandrogenic state. However, a level &gt; 2 ng/ml is quite high and not a typical threshold for PCOS diagnosis. Elevated testosterone in PCOS is usually more modest.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Infertility</strong>: Correct. Infertility is a common complication of PCOS due to chronic anovulation (lack of ovulation). Many women with PCOS struggle with infertility or subfertility.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>High FSH/LH Ratio</strong>: This is incorrect. In PCOS, the LH to FSH ratio is often elevated (reversed), not the FSH to LH ratio. A common finding is an LH to FSH ratio greater than 2:1.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Fasting Glucose/Insulin Ratio &gt; 4.5</strong>: Correct. &nbsp;While insulin resistance is a feature of PCOS, this specific ratio is not a standard diagnostic criterion for the condition. PCOS is often associated with insulin resistance, but diagnostic criteria typically don't include a specific fasting glucose/insulin ratio.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option E.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Polycystic Appearance on 1 or Both Ovaries on Ultrasound</strong>: Correct. One of the diagnostic criteria for PCOS, according to the Rotterdam criteria, is the presence of polycystic ovaries on ultrasound, characterized by 12 or more follicles measuring 2-9 mm in diameter, or an increased ovarian volume (&gt;10 cm³) in one or both ovaries.</span></p><p style=\"text-align:justify;\"><br><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovarian disease (PCOD/PCOS) is characterized by features such as hyperandrogenism (e.g., elevated testosterone levels), infertility due to chronic anovulation, and polycystic ovaries on ultrasound. Understanding these features is key in the diagnosis and management of PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 411, Speroff’s clinical gynaecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12115,
      "choices": [
        {
          "id": 48424,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marked elevation of LH in contrast to FSH</span></span></span></span></p>"
        },
        {
          "id": 48425,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin resistance</span></span></span></span></p>"
        },
        {
          "id": 48426,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevation of plasma testosterone</span></span></span></span></p>"
        },
        {
          "id": 48427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevation in the levels of sex hormone binding globulin (SHBG)</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The biochemical chaanges in established cases of Stein-Leventhal syndrome are all except?</span></span></p>",
      "unique_key": "Q8938157",
      "question_audio": null,
      "question_video": null,
      "map_id": 18821,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Elevation in the levels of sex hormone binding globulin (SHBG)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stein Leventhal syndrome is the older name of PCOS</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In PCOS (Stein Leventhal syndrome) the levels of SHBG decrease</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other features of PCOS are</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH: FSH ratio is increased (3:1) i.e. LH is more than FSH</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase free testosterone levels. </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase DHEAS</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fasting glucose: insulin ratio &lt; 4.5</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sex hormone binding globulin decreases.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s examine each statement:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marked elevation of LH in contrast to FSH</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. In PCOS, there is often a marked elevation of LH relative to FSH, leading to an increased LH:FSH ratio. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin Resistance</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Insulin resistance is a common finding in PCOS, contributing to its pathophysiology. It is associated with an increased risk of type 2 diabetes and other metabolic complications in these patients.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevation of Plasma Testosterone</strong>: Correct. Hyperandrogenism, characterized by elevated levels of testosterone, is a hallmark of PCOS. This leads to symptoms such as hirsutism, acne, and androgenic alopecia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevation in the Levels of Sex Hormone Binding Globulin (SHBG)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. In PCOS, there is typically a decrease in the levels of SHBG. Lower levels of SHBG result in increased bioavailability of testosterone, contributing to the hyperandrogenic symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In PCOS, biochemical changes include an elevated LH:FSH ratio, insulin resistance, increased levels of plasma testosterone, and decreased levels of SHBG. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 411 Speroff&rsquo;s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12117,
      "choices": [
        {
          "id": 48432,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovaries</span></span></span></span></p>"
        },
        {
          "id": 48433,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></span></p>"
        },
        {
          "id": 48434,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pelvic inflammatory disease</span></span></span></span></p>"
        },
        {
          "id": 48435,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most likely diagnosis in a 28-year-old obese woman presenting with Oligomenorrhea, infertility and hirsutism?</span></span></span></span></p>",
      "unique_key": "Q6892119",
      "question_audio": null,
      "question_video": null,
      "map_id": 18822,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Polycystic ovaries</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young woman presenting in the third decade with obesity, oligomenorrhea, infertility and hirsutism leaves no doubt for the diagnosis of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to Rotterdam criteria &rarr; PCOD is diagnosed if any 2 of 3 of the following criteria are being fulfilled:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovulatory dysfunction such as oligomenorrhea or hyperandrogenism.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical or biochemical evidence of hyperandrogenism</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">USG criteria (1 or both ovaries showing polycystic appearance)</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since this woman has oligomenorrhea and hirsutism, SO2 of the criteria are being fulfilled.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is a condition where endometrial tissue grows outside the uterus. It commonly presents with painful periods, chronic pelvic pain, and can be associated with infertility. However, it does not typically present with hirsutism or oligomenorrhea as primary symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pelvic Inflammatory Disease (PID)</strong>: PID is an infection of the female reproductive organs, often caused by sexually transmitted infections. It typically presents with pelvic pain, fever, and abnormal vaginal discharge.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing Syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cushing syndrome is caused by prolonged exposure to high levels of cortisol. It can present with obesity, menstrual irregularities, and hirsutism. However, the other symptoms of Cushing&#39;s syndrome (like a round face, high blood pressure, and purple stretch marks) are not mentioned, making PCOS a more likely diagnosis in this case.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Polycystic Ovary Syndrome (PCOS) should be highly suspected in women presenting with a combination of oligomenorrhea, infertility, hirsutism, and often obesity. PCOS is a complex endocrine disorder that impacts multiple aspects of health and is a common cause of infertility in women.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 400, Speroff&rsquo;s clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48432,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12118,
      "choices": [
        {
          "id": 48436,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">17-OH progesterone</span></p>"
        },
        {
          "id": 48437,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">DHEA</span></p>"
        },
        {
          "id": 48438,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Testosterone</span></p>"
        },
        {
          "id": 48439,
          "text": "<p><span style=\"font-size:12.0pt;\">LH: FSH ratio</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Preeti, a 20-year-old girl presents with a history of rapidly developing hirsutism, severe acne and amenorrhea. Her BMI is 19. To establish the diagnosis, which would be the most appropriate blood test?</span></p>",
      "unique_key": "Q3941819",
      "question_audio": null,
      "question_video": null,
      "map_id": 18823,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. Testosterone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">For cases of virilisation and hirsutism, serum testosterone is the investigation of choice</span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">A variety of ovarian neoplasms, both benign and malignant may produce testosterone and lead to virilization. Specifically, women with an abrupt onset, typically within several months, or sudden worsening of virilizing signs should prompt concern for a hormone producing ovarian or adrenal tumour.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Symptoms may include deepening of voice, frontal balding, severe acne, or hirsutism or both, increased muscle mass and clitoromegaly.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Accordingly, serum testosterone levels may be used to exclude these tumours. Free testosterone levels are more sensitive than total testosterone levels as an indicator of hyperandrogenism.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">\"Threshold values beyond 200 ng/dl of total testosterone warrant evaluation for an ovarian lesion\".</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Testosterone estimation is the best investigation in case of rapid onset hirsutism and amenorrhea.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">M/C cause of rapid onset hirsutism in young females = Testosterone producing tumour</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">DHEA sulphate is produced exclusively by the adrenal gland. Therefore, serum DHEAS levels above 700 mcg/dl are highly sensitive&nbsp;for the presence of an adrenal neoplasm.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Adrenal imaging with abdominal CT or MRI is indicated for any patient with DHEAS levels that exceed this value.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Let us look at each option separately:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. A.</strong> <strong>17-OH Progesterone</strong>: This test is used to evaluate adrenal gland function and diagnose congenital adrenal hyperplasia (CAH), a condition that can cause symptoms similar to PCOS, including hirsutism and menstrual irregularities. However, the rapid onset of symptoms described is less typical for CAH.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. B.</strong> <strong>DHEA (Dehydroepiandrosterone)</strong>: DHEA is an androgen produced by the adrenal glands. While elevated levels can contribute to hirsutism and acne, DHEA alone may not provide a definitive diagnosis in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C.</strong>&nbsp;<strong>Testosterone</strong>: Correct. Elevated levels of testosterone are a key indicator of hyperandrogenism, which can manifest as hirsutism, acne, and menstrual irregularities. Measuring testosterone levels is crucial in diagnosing conditions like PCOS or androgen-secreting tumors, which can present with rapid onset of symptoms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. D.</strong> <strong>LH: FSH Ratio</strong>: This ratio is often evaluated in the diagnosis of PCOS, as women with PCOS may have an elevated ratio. However, <strong>a normal ratio does not rule out PCOS, and it is not as directly indicative of hyperandrogenism as elevated testosterone levels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">When evaluating a young woman with rapid onset of hirsutism, severe acne, and amenorrhea, measuring serum testosterone levels is crucial for diagnosing conditions associated with hyperandrogenism, such as PCOS or androgen-secreting tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref: Page 449, Speroff’s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48438,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12120,
      "choices": [
        {
          "id": 48444,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomenorrhea</span></span></span></span></p>"
        },
        {
          "id": 48445,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sonographic polycystic appearance of ovaries</span></span></span></span></p>"
        },
        {
          "id": 48446,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral distribution of follicles on transvaginal ultrasonography</span></span></span></span></p>"
        },
        {
          "id": 48447,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical signs of hyperandrogenism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not included in Rotterdam criteria?</span></span></p>",
      "unique_key": "Q6164420",
      "question_audio": null,
      "question_video": null,
      "map_id": 18824,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Peripheral distribution of follicles on transvaginal ultrasonography</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomenorrhea/ anovulation</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical or biochemical sign of hyperandrogenism</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound features of polycystic ovaries</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound&nbsp;features which are considered for diagnosis of polycystic ovaries includes the presence of these in one or both ovaries</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ge;12 follicles measuring 2&ndash;9 mm throughout the entire ovary.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased ovarian volume of &gt; 10 cm3</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A single ovary complying these features is sufficient for diagnosing as polycystic <strong>ovaries(PCO) </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us evaluate each option to identify which is not included in these criteria:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomenorrhea</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Included. Oligomenorrhea, or infrequent menstrual periods, is one of the criteria under the Rotterdam guidelines for diagnosing PCOS. It reflects the chronic anovulation commonly seen in PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sonographic Polycystic Appearance of Ovaries</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Included. The presence of polycystic ovaries on ultrasound is a part of the Rotterdam criteria. This is typically defined as having 12 or more follicles in each ovary measuring 2-9 mm in diameter, or increased ovarian volume.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peripheral Distribution of Follicles on Transvaginal Ultrasonography</strong>: Not included. While the presence of multiple follicles is a criterion, the specific pattern of their distribution, such as a peripheral arrangement, is not a requirement for the diagnosis of PCOS as per the Rotterdam criteria.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Signs of Hyperandrogenism</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Included. Clinical signs of hyperandrogenism, such as hirsutism, acne, or androgenic alopecia, are part of the Rotterdam criteria. Alternatively, biochemical signs of hyperandrogenism can also fulfill this criterion.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Rotterdam criteria for the diagnosis of PCOS include at least two of the following: oligomenorrhea or amenorrhea, clinical or biochemical signs of hyperandrogenism, and polycystic ovaries on ultrasound. The specific distribution pattern of ovarian follicles is not a part of these diagnostic criteria.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 400, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12121,
      "choices": [
        {
          "id": 48448,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases LH production</span></span></span></span></p>"
        },
        {
          "id": 48449,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces production of FSH</span></span></span></span></p>"
        },
        {
          "id": 48450,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acts on androgen receptors and antagonizes it</span></span></span></span></p>"
        },
        {
          "id": 48451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces ovarian androgen production</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19y girl with PCOS is started on the combination pill shown below. What is the role of the progesterone component of this combination?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture10.jpg\" style=\"height:177px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q9835423",
      "question_audio": null,
      "question_video": null,
      "map_id": 18825,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Reduces ovarian androgen production</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen production in PCOD women usually is an LH-dependent process. PROGESTINS in oral contraceptives suppress pituitary LH secretion and thus also suppress ovarian androgen production.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Progestin in oral contraceptives inhibit 5&alpha; reductase activity in skin which decreases the production of dihydrotestosterone (DHT), the major nuclear androgen in hair follicles and sebaceous glands.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s consider the role of the progesterone component:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases LH Production</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Progestins in oral contraceptive pills (OCPs), including Drosperinone, do not increase LH production. Instead, they help suppress ovulation partly by inhibiting the release of gonadotropins like LH from the pituitary gland.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces Production of FSH</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Progestins contribute to the suppression of FSH production, which is a mechanism involved in preventing ovulation. However, this is not the most direct effect of drospirenone in the context of PCOS treatment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acts on Androgen Receptors and Antagonizes it</strong>: Drosperinone has anti-androgenic properties, meaning it can counteract the effects of androgens. This action helps reduce symptoms like acne and hirsutism in PCOS but is not its primary mechanism of action in terms of ovarian androgen production.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces Ovarian Androgen Production</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. One of the key roles of drospirenone in OCPs for PCOS is to reduce ovarian androgen production. By suppressing gonadotropin release (LH and FSH), drospirenone reduces the stimulation of the ovaries, leading to decreased production of androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In the treatment of PCOS, Drosperinone in combination oral contraceptive pills helps reduce ovarian androgen production by suppressing gonadotropin release. This action not only aids in regulating the menstrual cycle but also helps in managing hyperandrogenic symptoms such as acne and hirsutism commonly seen in PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 420, Speroff&rsquo;s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48451,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12122,
      "choices": [
        {
          "id": 48452,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic alopecia</span></span></span></span></p>"
        },
        {
          "id": 48453,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased facial hair</span></span></span></span></p>"
        },
        {
          "id": 48454,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly</span></span></span></span></p>"
        },
        {
          "id": 48455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following features are seen in PCOS except?</span></span></span></span></p>",
      "unique_key": "Q5053520",
      "question_audio": null,
      "question_video": null,
      "map_id": 18826,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Clitoromegaly</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features seen in PCOD are:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic alopecia</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased facial hair</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menstrual irregularity</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In PCOD there is increased androgen production which is LH mediated and lead to growth of terminal hairs on the face or body in a male pattern</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly is not seen in PCOD.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism defined as excessive male pattern facial and body hair</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Virilization is defined by the signs and symptoms of more severe androgen excess which include deepening of voice, clitoromegaly, balding and breast atrophy.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hair is characterized as <strong>vellus</strong> that is fine, soft, and unpigmented or <strong>terminal </strong>i.e long, coarse and pigmented</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In androgen sensitive areas androgen stimulates growth of longer, thicker, and darker hairs.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hair follicles testosterone needs to be converted to dihydrotestosterone by 5&alpha; reductase. Dihydrotestosterone is the main hormone which plays a crucial role in hair growth.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Let us look at each option</strong>:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic Alopecia: Seen&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in PCOS. Androgenic alopecia, or male-pattern hair loss, can occur in PCOS due to the effects of elevated androgens on hair follicles.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased Facial Hair</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Seen in PCOS. Hirsutism, or increased facial and body hair in a male pattern, is a common feature of PCOS, resulting from increased androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clitoromegaly</strong>: Not seen in PCOS. Clitoromegaly, or an enlarged clitoris, is a sign of virilization and is more indicative of conditions with severe androgen excess, such as congenital adrenal hyperplasia or androgen-secreting tumors. It is not a characteristic feature of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Seen in PCOS. Acne is a common dermatological manifestation in PCOS, also related to elevated androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Polycystic ovary syndrome (PCOS) is characterized by signs of hyperandrogenism, such as hirsutism, acne, and androgenic alopecia, along with menstrual irregularities. Clitoromegaly is not a typical feature of PCOS and is more indicative of conditions with more severe androgen excess. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 449, Speroff&rsquo;s Clinical Gynaecological Endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12124,
      "choices": [
        {
          "id": 48460,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Insulin resistance</span></p>"
        },
        {
          "id": 48461,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Cushing syndrome</span></p>"
        },
        {
          "id": 48462,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Androgen producing tumors</span></p>"
        },
        {
          "id": 48463,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital adrenal hyperplasia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"background-color:transparent;font-size:16px;\">During evaluation of PCOS, a serum 17 –hydroxyprogesterone levels of 800 ng/dl was obtained. This value warrants the diagnosis of?</span></p>",
      "unique_key": "Q3245742",
      "question_audio": null,
      "question_video": null,
      "map_id": 18827,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D. Congenital adrenal hyperplasia</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">CONGENITAL ADRENAL HYPERPLASIA is caused by adrenal enzyme deficiency of most commonly 21 hydroxylase that results in excessive adrenal androgen production.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Non classical or late onset CAH present later during life with signs of hyperandrogenism, very much like in PCOD.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Specific testing for CAH is usually reserved for those having early onset hirsutism (pre or peri-menarchal), women with family history of disorder and high-risk ethnic groups like Ashkenazi Jews.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A follicular phase morning serum 17 OHP concentration less than 200ng/dl, excludes and a level greater than 800 ng/dl establishes the diagnosis of CAH.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Between values of 200-800 ACTH stimulation test needs to be done with intramuscular injection of 0.25 mg ACTH , if the 17 OHP concentration will rise above 1500 mg/dL, it is diagnostic for CAH.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Insulin Resistance</strong>: Insulin resistance is a common feature of PCOS but is not directly indicated by elevated 17-hydroxyprogesterone levels. Insulin resistance is typically assessed through glucose tolerance tests or measurements of fasting insulin levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cushing Syndrome</strong>: Cushing syndrome is characterized by excessive cortisol production. While it can present with features like PCOS, such as weight gain and menstrual irregularities, elevated 17-hydroxyprogesterone is not a typical finding in Cushing's.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Androgen Producing Tumors</strong>: Androgen-producing tumors can cause symptoms similar to PCOS. However, elevated 17-hydroxyprogesterone levels are more indicative of adrenal disorders like congenital adrenal hyperplasia rather than androgen-producing tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Congenital Adrenal Hyperplasia (CAH)</strong>: Correct. Elevated levels of 17-hydroxyprogesterone are a key indicator for congenital adrenal hyperplasia, particularly the 21-hydroxylase deficiency form. In the context of PCOS evaluation, an abnormally high level of 17-hydroxyprogesterone warrants further investigation to exclude CAH.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When evaluating a patient for PCOS, a significantly elevated level of 17-hydroxyprogesterone, as in this case, suggests the need to exclude congenital adrenal hyperplasia, especially the 21-hydroxylase deficiency variant. CAH can mimic many symptoms of PCOS, including hyperandrogenism and menstrual irregularities.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page 449, Speroff’s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48463,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12125,
      "choices": [
        {
          "id": 48464,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Male pattern hair growth on lower abdomen</span></p>"
        },
        {
          "id": 48465,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Thickened dark skin on inner thighs</span></p>"
        },
        {
          "id": 48466,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Abnormal glucose tolerance test results</span></p>"
        },
        {
          "id": 48467,
          "text": "<p><span style=\"color:black;font-size:12pt;\">High serum levels of high-density lipoproteins</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 19-year-old girl with a long-standing history of irregular menstrual cycles and amenorrhea presents with an ultrasound picture shown below. Which of the following is least likely to be seen in her?</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture11_c5RSZPQ.jpg\" alt=\"\" width=\"300\" height=\"229\"></span></p>",
      "unique_key": "Q4546560",
      "question_audio": null,
      "question_video": null,
      "map_id": 18828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D.&nbsp;High serum levels of high-density lipoproteins</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOD&nbsp;women shows chronic anovulation and commonly shows insulin resistance which is associated with acanthosis and thickening of skin.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Insulin resistance leads to abnormal glucose tolerance detected using GTT with 75 gm glucose.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Upto10% of women with PCOS develop diabetes by age 40.</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Metabolic abnormalities in PCOD</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Elevated androgen level leads to increased LDL levels</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Increased triglyceride levels (&gt;150mg/dl)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Normal or decreased HDL levels(&lt;50mg/dl)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hyperinsulinemia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Central obesity with increased waist circumference (&gt;88 cm)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let consider each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. A.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Male Pattern Hair Growth on Lower Abdomen</strong>: Likely. Hirsutism, or male pattern hair growth, is a common feature in PCOS due to hyperandrogenism. This can include hair growth on the lower abdomen.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Thickened Dark Skin on Inner Thighs</strong>: Likely. Acanthosis nigricans, characterized by thickened and darkened skin, often in areas like the neck and inner thighs, is commonly associated with insulin resistance, a condition often seen in PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Abnormal Glucose Tolerance Test Results</strong>: Likely. Women with PCOS are at increased risk for insulin resistance and type 2 diabetes. An abnormal glucose tolerance test is a common finding and reflects impaired insulin sensitivity.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>High Serum Levels of High-Density Lipoproteins (HDL)</strong>: Least likely. PCOS is often associated with a dyslipidemic profile, which typically includes lower levels of HDL (\"good\" cholesterol) and higher levels of LDL (\"bad\" cholesterol) and triglycerides. <strong>High levels of HDL are not characteristic of the metabolic disturbances commonly seen in PCOS.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOS is often associated with signs of hyperandrogenism like hirsutism, metabolic issues such as insulin resistance and abnormal glucose tolerance, and a dyslipidemic profile with lower HDL levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ref: Page 400, Speroff’s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48467,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12128,
      "choices": [
        {
          "id": 48476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pancreas</span></span></span></span></p>"
        },
        {
          "id": 48477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Adrenal</span></span></span></span></p>"
        },
        {
          "id": 48478,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ovary</span></span></span></span></p>"
        },
        {
          "id": 48479,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pituitary</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During detailed workup of PCOD in a 19-year-old patient shown below is noted to have a serum total testosterone level of 375 ng/dl with rapidly increasing hirsutism. Which of the following endocrine glands is likely to harbour the androgen producing tumour?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture12_CA3vfPf.jpg\" style=\"height:195px; width:250px\" /></span></span></span></p>",
      "unique_key": "Q6129644",
      "question_audio": null,
      "question_video": null,
      "map_id": 18829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp; Ovary </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shown is hirsutism. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When the serum total testosterone concentration (&gt;150ng/dl) or the clinical presentation suggests the possibility of rare androgen producing ovarian or adrenal tumours, remember that ovarian tumours are more common than adrenal tumours</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen secreting tumours of the ovary include</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertoli-Leydig tumours</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lipid cell tumours</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theca cell tumours</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brenners tumour</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Transvaginal ultrasound is gold standard to detect such tumour.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal tumours are identified by adrenal CT.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most androgen producing adrenal tumours are malignant.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Adrenal adenomas are smaller than carcinoma and have smooth borders. CT features of irregular margin, necrosis, haemorrhage, or calcification suggest a carcinoma.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selective ovarian venous catheterization can be considered for the rare patient having no demonstrable ovarian or adrenal mass lesion.</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s consider the potential source of an androgen-producing tumour:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreas</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The pancreas is not typically a source of androgen-producing tumours. It primarily functions in insulin and digestive enzyme production, and its pathologies are not usually associated with elevated androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Adrenal tumours can produce androgens, leading to symptoms like hirsutism. However, ovarian tumours are more common causes of elevated androgens in women. Adrenal tumours are less frequent and are usually identified with adrenal CT imaging.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ovary</strong>: Correct. Ovarian tumours, such as Sertoli-Leydig cell tumours, lipid cell tumours, theca cell tumours, or Brenner tumours, can secrete high levels of androgens. Given the high serum testosterone level and the clinical presentation, an ovarian source is more likely than an adrenal source. Transvaginal ultrasound is typically used for initial evaluation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ption. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pituitary</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pituitary tumours, such as prolactinomas or adenomas producing ACTH, can affect menstrual cycles and hormonal balance, but they are not known for directly secreting androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In cases of PCOD with significantly elevated serum testosterone levels and rapidly increasing hirsutism, an androgen-secreting ovarian tumour should be considered. Ovarian tumours are a more common source of excess androgens in women compared to adrenal tumours. Transvaginal ultrasound is the gold standard for detecting such ovarian tumours, while adrenal tumours are identified with adrenal CT imaging</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 449, Speroff&rsquo;s Clinical Gynaecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12130,
      "choices": [
        {
          "id": 48484,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Insulin</span></span></span></span></p>"
        },
        {
          "id": 48485,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dehydroepiandrosterone (DHEA)</span></span></span></span></p>"
        },
        {
          "id": 48486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Metformin</span></span></span></span></p>"
        },
        {
          "id": 48487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Progesterone</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications added to clomiphene has been found to be associated with improvement in ovulation response?</span></span></p>",
      "unique_key": "Q6041685",
      "question_audio": null,
      "question_video": null,
      "map_id": 18830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Metformin</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Majority of both lean and obese women with PCOS ARE INSULIN RESISTANT</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin improves menstrual cyclicity and ovulatory function in women with PCOS.</span></span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most appropriate candidate for treatment with metformin along with clomiphene are those:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With impaired glucose tolerance or diabetes</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Those with obvious signs of insulin resistance such as acanthosis nigricans</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with features of metabolic syndrome such as obesity, dyslipidemia, and hypertension</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While insulin resistance is a common feature in PCOS, adding insulin itself is not a standard treatment for improving ovulation. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>&nbsp;</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DHEA is a precursor to sex hormones and is sometimes used as a supplement in various fertility treatments. However, its addition to clomiphene for improving ovulation response in PCOS is not well-established or widely recommended.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Progesterone</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Progesterone is used in various contexts in reproductive medicine, but it is not typically added to clomiphene to improve ovulation. Its primary use is in the luteal phase support in assisted reproductive technologies and to induce menstrual cycles in cases of amenorrhea.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Metformin, when used alongside clomiphene, can improve the ovulation response in women with PCOS, particularly those with insulin resistance or metabolic syndrome. Metformin improves insulin sensitivity, thereby enhancing the effectiveness of clomiphene in inducing ovulation</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 424, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48486,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12132,
      "choices": [
        {
          "id": 48492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">20</span></span></span></span></p>"
        },
        {
          "id": 48493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">30</span></span></span></span></p>"
        },
        {
          "id": 48494,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">40</span></span></span></span></p>"
        },
        {
          "id": 48495,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">50</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year nulligravida married for 4 years with irregular menstrual cycles was being evaluated for infertility. On ultrasonography she has 14 follicles measuring 2-8 mm diameter per ovary (USG picture shown below). What percentage of young women without PCOS will exhibit a similar ultrasonographic picture?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture13_I3ijK3t.jpg\" style=\"height:173px; width:250px\" /></span></span></p>",
      "unique_key": "Q3972192",
      "question_audio": null,
      "question_video": null,
      "map_id": 18831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. 20</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8-25% of normal women and 14% of women using OCP meet the USG criteria for PCOD</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus option A) 20 % is correct.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound features which are considered for diagnosis of polycystic ovaries includes:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ge;12 follicles measuring 2&ndash;9 mm <em>throughout the entire ovary </em></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">increased ovarian volume of &gt; 10 cm3</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No subjective assessment of stromal echogenicity and/or follicular distribution pattern required. </span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A single ovary complying these features is sufficient for diagnosing as polycystic <strong>ovaries(PCO) </strong></span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Studies have demonstrated that without the symptoms of polycystic ovary syndrome, a PCO appearance alone is not associated with impaired fertility</span></span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While up to 25% of normal women can exhibit polycystic ovaries on ultrasound, it&#39;s crucial to remember that this finding alone, in the absence of clinical symptoms of PCOS, does not indicate impaired fertility or PCOS. The diagnosis of PCOS should be based on a combination of clinical signs, symptoms, and ultrasound findings</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 401, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12134,
      "choices": [
        {
          "id": 48500,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"color:black\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reverses endometrial hyperplasia</span></span></span></span></p>"
        },
        {
          "id": 48501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"color:black\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases angiotensinogen production</span></span></span></span></p>"
        },
        {
          "id": 48502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"color:black\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduces LH levels in the blood</span></span></span></span></p>"
        },
        {
          "id": 48503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"color:black\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases SHBG production</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old nulliparous female was advised the following contraceptives for irregular periods and hormonal imbalance. Ethinyl estradiol has which of the following effects?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture14_jD940aa.jpg\" style=\"height:148px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3897882",
      "question_audio": null,
      "question_video": null,
      "map_id": 18832,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Increases SHBG production</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrogen &ndash; progestin contraceptives have several complimentary non contraceptive effect actions that make them effective treatment for menstrual irregularities and hirsutism seen in PCOD.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The high levels of estrogen in combination contraceptives stimulates hepatic production of SHBG thereby increasing binding capacity for circulating androgens and decreasing the amount of free active androgen.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrogen induces a dose dependent increase in SHBG concentrations.<br />\r\n\tEstrogen component also suppresses FSH in HPO axis</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us &nbsp;consider each option:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reverses Endometrial Hyperplasia</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While estrogens can influence the endometrium, they are not typically used alone to reverse endometrial hyperplasia. Progestins are more commonly used for this purpose, as unopposed estrogen can actually increase the risk of endometrial hyperplasia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases Angiotensinogen Production</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Estrogens can increase the production of angiotensinogen in the liver, which can have effects on blood pressure regulation. However, this is not the primary reason for using ethinyl estradiol in combination contraceptives for menstrual irregularities and hormonal imbalance.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reduces LH Levels in the Blood</strong>: Estrogen components in oral contraceptives can suppress LH secretion as part of the feedback mechanism on the hypothalamic-pituitary-ovarian axis. However, this suppression is typically achieved in combination with a progestin component.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases SHBG Production</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Ethinyl estradiol stimulates hepatic production of sex hormone-binding globulin (SHBG), which binds free testosterone in the bloodstream, thus reducing the level of free and bioavailable androgens. This effect is beneficial in conditions like PCOS, where hyperandrogenism is a concern.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The estrogen component of combination contraceptives, such as ethinyl estradiol, increases the production of sex hormone-binding globulin (SHBG) in the liver. This leads to a reduction in free and bioavailable androgens, which can be beneficial in managing conditions like PCOS that are characterized by hyperandrogenism. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 425, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12136,
      "choices": [
        {
          "id": 48508,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It should be performed as 1<sup>st</sup> line of treatment in women seeking fertility issues in PCOS</span></span></span></span></p>"
        },
        {
          "id": 48509,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A minimum of 10 drills in each ovary should be made</span></span></span></span></p>"
        },
        {
          "id": 48510,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is used to mainly treat </span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hirsutism</span></span></span></p>"
        },
        {
          "id": 48511,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It can lead to a reduction in AMH levels</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30yr subfertile&nbsp; woman who has not responded to ovulation induction with clomiphene citrate undergoes a procedure as shown.&nbsp; What is true about the procedure being shown?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture15_vtXSqXI.jpg\" style=\"height:187px; width:250px\" /></span></span></span></p>",
      "unique_key": "Q5009895",
      "question_audio": null,
      "question_video": null,
      "map_id": 18833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. It can lead to a reduction in AMH levels</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The procedure shown in Laparoscopic Ovarian Drilling</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic ovarian drilling is used in place of wedge resection (earlier done) in patients with severe PCOS resistant to clomiphene and have even tried ovulation with gonadotropins </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Procedure involves use of electrocautery monopolar needle inserted at a cutting current of 100 W for entry and <strong>40W</strong> coagulation to treat stroma for a time of <strong>4 seconds. </strong>In each ovary <strong>4 punctures </strong>are done to reduce adhesion formation to a depth of <strong>4 mm (rule of 4)</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of the studies report reduction in both androgen and LH concentration and an increase in FSH concentration.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a fall in AMH levels following the procedure </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, there is risk of adhesion formation in patients and should be discussed with the patient.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The beneficial effects are sustained for up to 5 years.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s evaluate each statement about this procedure:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should be Performed as 1st Line of Treatment in Women Seeking Fertility Issues in PCOS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Ovarian drilling is not the first line of treatment for fertility issues in women with PCOS. Initial treatments usually involve lifestyle modifications and medications like clomiphene citrate or letrozole for ovulation induction. Ovarian drilling is considered when these initial treatments fail.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Minimum of 10 Drills in Each Ovary Should be Made</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. The exact number of drills made during ovarian drilling is variable and depends on the surgeon&#39;s discretion and the patient&#39;s specific condition. However, making too many drills can damage the ovarian tissue and is not typically recommended.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Used to Mainly Treat Hirsutism</strong>: Incorrect. Ovarian drilling is primarily used to induce ovulation in women with PCOS who are resistant to other forms of treatment. While it may have some effect on androgen levels, its main purpose is not to treat hirsutism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can Lead to a Reduction in AMH Levels</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Ovarian drilling can lead to a reduction in anti-M&uuml;llerian hormone (AMH) levels. AMH is a marker of ovarian reserve, and ovarian drilling, by its nature, can reduce the number of antral follicles, thereby decreasing AMH levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ovarian drilling is a surgical option for inducing ovulation in women with PCOS who are resistant to first-line treatments like clomiphene citrate. While it can be effective in inducing ovulation, it can also lead to a reduction in AMH levels, indicating a decrease in ovarian reserve. It is not primarily used for treating hirsutism and should not be the first-line treatment for fertility issues in PCOS</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 424, Speroff&rsquo;s Clinical Gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48511,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12138,
      "choices": [
        {
          "id": 48516,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 48517,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">HMG</span></p>"
        },
        {
          "id": 48518,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Clomiphene</span></p>"
        },
        {
          "id": 48519,
          "text": "<p><span style=\"font-size:12.0pt;\">Ormeloxifene</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All the following are ovulation induction option in PCOD except?</span></p>",
      "unique_key": "Q2801003",
      "question_audio": null,
      "question_video": null,
      "map_id": 18834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D. Ormeloxifene</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic ovarian syndrome is a common disorder relating to ovulation problems</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The 1<sup>st</sup> line of management in a woman desirous of fertility in PCOS in Letrozole (Recent ESHRE guidelines)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Earlier Clomiphene citrate was the drug of choice but has mostly been replaced with letrozole.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gonadotropins are used when there is inability to induce ovulation with letrozole or clomiphene. Gonadotropins are used in clomiphene failure.&nbsp; (2<sup>nd</sup> line management)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When PCOD women do not ovulate with gonadotropins laparoscopic ovarian drilling is planned.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Metformin in combination with clomiphene increases ovulation and pregnancy rate as compared to clomiphene alone.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Ormeloxifene (Centchroman) is</span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A Selective Estrogen Receptor Modulator</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">It is a&nbsp; non-steroidal oral contraceptive used in a dose of 30mg twice weekly for 3 months and then weekly dose for contraception</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">It is also used for heavy menstrual bleeding in 60 mg twice weekly.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">It does not induce ovulation.</span></p></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at the other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. A.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Metformin</strong>: Metformin is used in PCOS primarily for its insulin-sensitizing effects, which <strong>can help restore normal ovulation</strong>, especially in women with insulin resistance. It's often used in combination with other ovulation-inducing drugs.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Human Menopausal Gonadotropin (HMG)</strong>: HMG, which contains a mixture of FSH and LH, is used to induce ovulation in women who do not respond to clomiphene. It directly stimulates the ovaries to produce follicles.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Clomiphene</strong>: Clomiphene citrate is a first-line therapy for ovulation induction in women with PCOS. It works by blocking estrogen receptors, leading to increased release of FSH and LH, which in turn stimulates follicular growth.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In PCOS, ovulation induction can be achieved with medications like clomiphene citrate, metformin (particularly in insulin-resistant patients), and human menopausal gonadotropin (HMG). Ormeloxifene, however, is not used for this purpose and is instead utilized for contraception and managing dysfunctional uterine bleeding.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page 424, Speroff’s Clinical Gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12140,
      "choices": [
        {
          "id": 48524,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More chances of multiple pregnancy</span></span></span></span></p>"
        },
        {
          "id": 48525,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More chances of ovulation</span></span></span></span></p>"
        },
        {
          "id": 48526,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No antiestrogenic effect on endometrium</span></span></span></span></p>"
        },
        {
          "id": 48527,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased chances of poly-follicular development</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23y old woman with PCOS and infertility is started on letrozole for ovulation induction. Letrozole is nowadays preferred over clomiphene in case of PCOS due to which of the following effect?</span></span></p>",
      "unique_key": "Q1027189",
      "question_audio": null,
      "question_video": null,
      "map_id": 18835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp; No antiestrogenic effect on endometrium</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Letrozole is an aromatase inhibitor. Orally absorbed and t&frac12; is 45h </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphene vs Letrozole:</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/18/screenshot-2024-03-18-152100.jpg\" style=\"height:416px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">let&#39;s examine each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More Chances of Multiple Pregnancy</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Letrozole actually has a lower risk of multiple pregnancies compared to clomiphene. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More Chances of Ovulation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While letrozole has been shown to be effective in inducing ovulation, especially in women with PCOS, its preference over clomiphene is not solely based on a higher ovulation rate. Both medications are effective for ovulation induction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>No Antiestrogenic Effect on Endometrium</strong>: Correct. One of the key advantages of letrozole over clomiphene is that it does not have the antiestrogenic effects on the endometrium and cervical mucus that clomiphene does. Clomiphene can lead to a thin endometrial lining, which can be counterproductive for conception.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased Chances of Poly-Follicular Development</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Letrozole typically results in a more physiologic ovulation process with fewer risks of poly-follicular development compared to clomiphene.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Letrozole is often preferred over clomiphene for ovulation induction in women with PCOS due to its lack of antiestrogenic effects on the endometrium. While both letrozole and clomiphene are effective in inducing ovulation, letrozole&#39;s more favorable impact on the endometrial lining makes it a better choice in certain scenarios, particularly in women with PCOS</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 424, Speroff&rsquo;s Clinical Gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12141,
      "choices": [
        {
          "id": 48528,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin resistance</span></span></span></span></p>"
        },
        {
          "id": 48529,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acanthosis Nigricans</span></span></span></span></p>"
        },
        {
          "id": 48530,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dyslipidemia</span></span></span></span></p>"
        },
        {
          "id": 48531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperandrogenism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common metabolic abnormality associated with PCOS is?<strong> &nbsp;</strong></span></span></p>",
      "unique_key": "Q4033156",
      "question_audio": null,
      "question_video": null,
      "map_id": 18836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Insulin Resistance</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin resistance is indeed one of the most common metabolic abnormalities associated with PCOS. It is a key factor in the pathophysiology of the syndrome and contributes to various other metabolic complications, including type 2 diabetes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nearly 70% have at least one borderline or elevated lipid level. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prevalence of obesity is around 50% in PCOS </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic abnormalities in PCOD</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated androgen level leads to increased LDL levels</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased triglyceride levels (&gt;150mg/dl)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal or decreased HDL levels(&lt;50mg/dl)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperinsulinemia</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Central obesity with increased waist circumference (&gt;88 cm)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acanthosis Nigricans</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Acanthosis nigricans, a skin condition characterized by darkened and thickened patches, often in the neck and groin areas, is associated with insulin resistance, a common feature in PCOS. However, it is more of a clinical sign than a metabolic abnormality.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperandrogenism</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hyperandrogenism, while a defining feature of PCOS, is more of an endocrine abnormality than a metabolic one. It manifests clinically as hirsutism, acne, and alopecia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The most common metabolic abnormality associated with PCOS is insulin resistance, which plays a central role in the pathophysiology of the syndrome and is linked to various metabolic complications. While dyslipidaemia is also common in PCOS, insulin resistance is more fundamental to the disorder&#39;s metabolic disturbances.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ref: Page 449,416, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</strong></span></span></span></span></p>",
      "correct_choice_id": 48528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12143,
      "choices": [
        {
          "id": 48536,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian malignancy</span></span></span></span></p>"
        },
        {
          "id": 48537,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive sleep apnoea</span></span></span></span></p>"
        },
        {
          "id": 48538,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial hyperplasia</span></span></span></span></p>"
        },
        {
          "id": 48539,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast malignancy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are long term effects of PCOS except?</span></span></p>",
      "unique_key": "Q4959948",
      "question_audio": null,
      "question_video": null,
      "map_id": 18837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D.&nbsp; Breast malignancy</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of PCOD should correct both its immediate and long-term clinical consequences which include:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menstrual irregularities</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of developing <strong>endometrial hyperplasia and neoplasia</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperandrogenism</span></span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infertility</span></span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of developing <strong>type 2 DM</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of developing <strong>cardiovascular disease</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OBESITY&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and associated <strong>obstructive sleep apnea</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in prevalence of <strong>anxiety, depression, and mood disorders</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic syndrome</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Even though PCOD is associated with Hyperestrogenic state there is no positive correlation with breast carcinoma and PCOD.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s analyze each option to determine which is not a long-term effect:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian Malignancy</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While PCOS is associated with a number of reproductive and metabolic complications, a direct link between PCOS and increased risk of ovarian cancer is not clearly established. PCOS is primarily associated with an increased risk of endometrial hyperplasia and cancer due to prolonged unopposed estrogen exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive Sleep Apnoea</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Obstructive sleep apnea is more common in women with PCOS, often related to the higher prevalence of obesity in this population. Obesity, a common feature in PCOS, is a risk factor for obstructive sleep apnoea.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Endometrial Hyperplasia</strong>: Correct. Women with PCOS are at an increased risk of endometrial hyperplasia and endometrial cancer due to chronic anovulation, leading to prolonged estrogen exposure without the counterbalancing effect of progesterone.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast Malignancy</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: exception. Despite the hyperestrogenic state associated with PCOS, there is no established positive correlation between PCOS and an increased risk of breast cancer. The increased risk of malignancy in PCOS is more specifically related to the endometrium.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While PCOS is associated with several long-term health consequences, including menstrual irregularities, infertility, metabolic syndrome, type 2 diabetes, cardiovascular disease, and endometrial hyperplasia, there is no established direct link between PCOS and an increased risk of breast cancer. The management of PCOS should address both its immediate symptoms and long-term health risks.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 416, Speroff&rsquo;s Clinical Gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48539,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12144,
      "choices": [
        {
          "id": 48540,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry of the peripheral blood</span></span></span></span></p>"
        },
        {
          "id": 48541,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum cortisol levels</span></span></span></span></p>"
        },
        {
          "id": 48542,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum 17-hydroxyprogesterone levels</span></span></span></span></p>"
        },
        {
          "id": 48543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum TSH</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infant is born with ambiguous genitalia. Although amniocentesis analysis during pregnancy showed a 46XX genotype, this infant has phallic-appearing genitalia and partially fused labia. You cannot palpate testes. Aside from a standard blood test, which biochemical screen is indicated?</span></span></p>",
      "unique_key": "Q7465395",
      "question_audio": null,
      "question_video": null,
      "map_id": 18838,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp; Serum 17-hydroxyprogesterone levels</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This infant likely has congenital adrenal hyperplasia (CAH).</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The classic form of 21-hydroxylase deficiency (21-OHD) is the most common cause of CAH.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has an incidence between 1 in 10,000 and 1 in 15,000 and is the most common cause of androgenization in chromosomal 46,XX females. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affected individuals are homozygous or compound heterozygous for severe mutations in the enzyme 21-hydroxylase (<em>CYP21A2</em>). This mutation causes a block in adrenal glucocorticoid and mineralocorticoid synthesis, increasing 17-hydroxyprogesterone and shunting steroid precursors into the androgen synthesis pathway.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased androgen synthesis in utero causes androgenization of the 46,XX fetus in the first trimester. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambiguous genitalia are seen at birth, with varying degrees of clitoral enlargement and labial fusion. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The salt-wasting form of 21-OHD results from severe combined glucocorticoid and mineralocorticoid deficiency. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A salt-wasting crisis usually manifests between 5 and 21 days of life and is a potentially life-threatening event that requires urgent fluid resuscitation and steroid treatment. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus, a diagnosis of 21-OHD should be considered in any baby with atypical genitalia with bilateral non palpable gonads.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow Cytometry of the Peripheral Blood</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Flow cytometry is not typically used in the initial evaluation of ambiguous genitalia. It is more commonly used for immunological analyses and is not directly relevant to determining the cause of ambiguous genitalia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum Cortisol Levels</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While serum cortisol levels might be relevant in cases of adrenal insufficiency, they are not the most direct initial test for an infant with ambiguous genitalia. Cortisol levels may be part of the broader evaluation but are not the primary test for diagnosing congenital adrenal hyperplasia (CAH).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum TSH</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is used to screen for thyroid disorders but is not the primary test for evaluating ambiguous genitalia. TSH levels would not typically be elevated in cases of CAH or other conditions leading to virilization.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In infants with ambiguous genitalia and a 46XX genotype, serum 17-hydroxyprogesterone levels should be assessed to screen for congenital adrenal hyperplasia, particularly 21-hydroxylase deficiency. This condition leads to increased androgen synthesis, causing virilization in chromosomal 46, XX females. Prompt diagnosis is crucial for appropriate management and prevention of potentially life-threatening adrenal crises.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Ref: Page 266, Speroff&rsquo;s Clinical Gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12146,
      "choices": [
        {
          "id": 48548,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Turner&rsquo;s syndrome</span></span></span></span></p>"
        },
        {
          "id": 48549,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pituitary adenoma</span></span></span></span></p>"
        },
        {
          "id": 48550,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;PCOS</span></span></span></span></p>"
        },
        {
          "id": 48551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral dysgerminoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young lady presents to the Gynecology OPD with complaints of primary infertility, excessive weight gain and hirsutism. Laparoscopy shows the following finding. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/02/picture1.jpg\" style=\"height:227px; width:266px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "unique_key": "Q5150173",
      "question_audio": null,
      "question_video": null,
      "map_id": 18839,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. PCOS&nbsp; </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic image shows bilaterally enlarged ovaries seen in Polycystic ovary syndrome</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS is a common functional disorder of the ovaries of unknown etiology. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A diagnosis of PCOS must meet 2 out of 3 criteria: Rotterdam Criteria</span></span></span></span>\r\n\t<ol>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen excess with clinical hyperandrogenism or elevated serum free or total testosterone</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian dysfunction with oligo/anovulation </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound showing polycystic morphology in 1 or both ovaries. </span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong><strong> </strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Turner&rsquo;s Syndrome:</strong> Turner&rsquo;s syndrome is characterized by the presence of a single X chromosome (45XO) and is typically associated with features such as short stature, webbed neck, and primary amenorrhea. It is not associated with PCOS-like symptoms or the laparoscopic findings described.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pituitary Adenoma</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A pituitary adenoma can cause menstrual irregularities and infertility due to hormonal imbalances, particularly if it is a prolactin-secreting adenoma. However, it would not cause the specific laparoscopic findings associated with PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral Dysgerminoma</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bilateral dysgerminoma is a rare type of ovarian tumor. The presentation would be more acute and could include abdominal pain or a palpable mass, which are not described in this scenario. The laparoscopic findings typical for PCOS are not consistent with dysgerminoma.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The most likely diagnosis for a young woman presenting with primary infertility, weight gain, hirsutism, and characteristic laparoscopic findings of enlarged, polycystic ovaries is PCOS. PCOS is a common endocrine disorder that affects women of reproductive age and is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 400, Speroff&rsquo;s Clinical Gynecological Endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48550,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12149,
      "choices": [
        {
          "id": 48560,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ectopic pregnancy </span></span></span></span></p>"
        },
        {
          "id": 48561,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">PCOS</span></span></span></span></p>"
        },
        {
          "id": 48562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometriosis </span></span></span></span></p>"
        },
        {
          "id": 48563,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">PID</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pearl necklace appearance is characteristic in?</span></span></span></span></p>",
      "unique_key": "Q2862718",
      "question_audio": null,
      "question_video": null,
      "map_id": 18840,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. PCOS</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">POLYCYSTIC OVARIAN DISEASE (PCOD)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a heterogeneous syndrome complex.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by chronic anovulation and hyperandrogenism.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Frequently associated with insulin resistance, resulting in menstrual irregularity, infertility &amp; hirsutism</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotterdam 2003 criteria for diagnosis of PCOS/PCOD&mdash;at least two out of three should be present</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligo/anovulation</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperandrogenism: biochemical or clinical</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On USG: Twelve or more than 12 follicles 2&ndash;9 mm in size present within one or both ovaries on USG and/or ovarian volume &gt;10 mL.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Principles of management include:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Irregular periods/amenorrhea = regularization of menses with OC pills/cyclical progesterone</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism/acne = suppression of androgens</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infertility = ovulation induction (preferred drug: Letrozole; Clomiphene citrate can also be given; 2<sup>nd</sup> line of drugs: Gonadotropins)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin sensitizers like metformin&nbsp; are also used to tackle insulin resistance</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ectopic Pregnancy</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The embryo implants outside the uterine cavity (most commonly in the fallopian tube). They might show an adnexal mass and an absence of an intrauterine gestational sac.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Endometriosis</strong>: It involves the growth of endometrial tissue outside the uterus, ultrasound findings vary and can include cysts (endometriomas) or adhesions.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PID (Pelvic Inflammatory Disease)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In PID, an infection of the female reproductive organs, ultrasound findings might include thickened fluid-filled fallopian tubes or other signs of inflammation. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The &quot;pearl necklace&quot; appearance on ultrasound, characterized by multiple small follicles around the periphery of the ovary, is a hallmark sign of PCOS. This appearance helps in the diagnosis of PCOS, a common endocrine disorder in women of reproductive age.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 400, Speroff&rsquo;s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12150,
      "choices": [
        {
          "id": 48564,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC pills </span></span></span></span></p>"
        },
        {
          "id": 48565,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclical progesterone</span></span></span></span></p>"
        },
        {
          "id": 48566,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myoinositol </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>"
        },
        {
          "id": 48567,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Danazol</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is not used in PCOS? </span></span></p>",
      "unique_key": "Q9205764",
      "question_audio": null,
      "question_video": null,
      "map_id": 18841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Danazol</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">POLYCYSTIC OVARIAN DISEASE (PCOD)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a heterogeneous syndrome complex.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by chronic anovulation and hyperandrogenism.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Frequently associated with insulin resistance, resulting in menstrual irregularity, infertility &amp; hirsutism</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotterdam 2003 criteria for diagnosis of PCOS/PCOD&mdash;at least two out of three should be present</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligo/anovulation</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperandrogenism: biochemical or clinical</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On USG: Twelve or more than 12 follicles 2&ndash;9 mm in size present within one or both ovaries on USG and/or ovarian volume &gt;10 mL.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Principles of management include:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Irregular periods/amenorrhea = regularization of menses with OC pills/cyclical progesterone</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism/acne = suppression of androgens</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infertility = ovulation induction (preferred drug: Letrozole; Clomiphene citrate can also be given; 2<sup>nd</sup> line of drugs: Gonadotropins)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin sensitizers like metformin&nbsp; are also used to tackle insulin resistance</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC Pills (Oral Contraceptive Pills)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Commonly prescribed in PCOS for regularizing menstrual cycles, decreasing androgen levels, and improving symptoms such as hirsutism and acne.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclical Progesterone</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cyclical progesterone can be used to induce regular menstrual bleeding, thereby reducing the risk of endometrial hyperplasia, which can result from anovulation and prolonged estrogen exposure in PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Myo-Inositol</strong>: Myo-inositol is a supplement that has been shown to improve insulin resistance and ovarian function in women with PCOS, and it may help in restoring fertility and normalizing menstrual cycles.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Danazol</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Not used in PCOS. Danazol is an androgenic medication primarily used in the treatment of endometriosis and fibrocystic breast disease. Due to its androgenic effects, it is not suitable for treating PCOS, a condition already characterized by hyperandrogenism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In PCOS, treatment options include oral contraceptive pills, cyclical progesterone, and supplements like myo-inositol, which help in managing symptoms and reducing long-term risks. Danazol, due to its androgenic properties, is not used in PCOS management, as it may exacerbate symptoms related to hyperandrogenism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 424, Speroff&rsquo;s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12152,
      "choices": [
        {
          "id": 48572,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Bishop score </span></span></span></span></p>"
        },
        {
          "id": 48573,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Rotterdam criteria</span></span></span></span></p>"
        },
        {
          "id": 48574,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Ferriman-Gallwey score </span></span></span></span></p>"
        },
        {
          "id": 48575,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;All of the above</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is used in quantifying hirsutism?</span></span></p>",
      "unique_key": "Q6848931",
      "question_audio": null,
      "question_video": null,
      "map_id": 18843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Ferriman-Gallwey score</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Ferriman-Gallwey Score: Method used for evaluating and quantifying hirsutism in women.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a score which quantifies the amount of hair (1-4) in 9 areas of the body (upper lip/ chin/ upper back/ lower back/ breast/ upper abdomen/ lower abdomen/ upper arm/ thighs)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A score of &gt; 8 is significant to call it clinical hyperandrogenism</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bishop Score</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Bishop score is used in obstetrics to assess the readiness of the cervix for labor, evaluating factors such as dilation, effacement, station, consistency, and position of the cervix</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotterdam Criteria</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Rotterdam criteria are used for diagnosing polycystic ovary syndrome (PCOS). They include hyperandrogenism (clinical or biochemical), oligo/anovulation, and polycystic ovaries on ultrasound.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the Above</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect, as only the Ferriman-Gallwey score is used for quantifying hirsutism. The Bishop score and Rotterdam criteria serve different purposes in obstetrics and PCOS diagnosis, respectively.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Ferriman-Gallwey score is the standardized method used to quantify the extent and severity of hirsutism. It assesses hair growth in various areas of the body that are typically less hairy in females, providing a useful tool in diagnosing and assessing the severity of conditions like PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 450, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12153,
      "choices": [
        {
          "id": 48576,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Acne</span></p>"
        },
        {
          "id": 48577,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Alopecia</span></p>"
        },
        {
          "id": 48578,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Clitoromegaly</span></p>"
        },
        {
          "id": 48579,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Testosterone level of 150 ng/dl</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following findings favor the diagnosis of androgenic tumor over PCOS in a woman presenting with amenorrhea and hirsutism?</span></p>",
      "unique_key": "Q6725010",
      "question_audio": null,
      "question_video": null,
      "map_id": 18844,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. Clitoromegaly</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>CLINICAL FEATURES OF PCOS:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">MC - Anovulatory infertility/amenorrhea/oligomenorrhea</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sometimes menorrhagia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Acanthosis nigricans – cutaneous marker of IR</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hirsutism</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Thick terminal hair with male pattern of distribution</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Acne</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Alopecia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Ferriman gallwey scoring ≥ 8</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Virilization – NEVER SEEN (seen in androgenic tumors)</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Clitoromegaly</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hoarseness of voice</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Increased muscle mass</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Male pattern baldness</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. A.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Acne</strong>: Acne is a common symptom of PCOS due to hyperandrogenism</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Alopecia</strong>: Androgenic alopecia (male-pattern hair loss) can occur in both PCOS and androgenic tumors due to increased androgen levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Clitoromegaly</strong>: Correct. Clitoromegaly, or enlargement of the clitoris, is a sign of significant androgen excess and is more suggestive of an androgen-secreting tumor than PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Testosterone Level of 150 ng/dl</strong>: While elevated testosterone levels are seen in PCOS, a level as high as 150 ng/dl is unusual and would raise suspicion for an androgen-secreting tumor. However, clitoromegaly is a more definitive clinical sign that favours an androgenic tumor over PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Clitoromegaly is a key clinical finding that favours the diagnosis of an androgen-secreting tumor over PCOS in a woman presenting with amenorrhea and hirsutism. This sign indicates a higher level of androgen excess than typically seen in PCOS. In contrast, symptoms like acne and alopecia can occur in both conditions.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page 449, Speroff’s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48578,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12158,
      "choices": [
        {
          "id": 48596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">A, B &amp; C are correct </span></span></span></p>"
        },
        {
          "id": 48597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">A &amp; B are correct </span></span></span></p>"
        },
        {
          "id": 48598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">C, D &nbsp;&amp; E are correct</span></span></span></p>"
        },
        {
          "id": 48599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:black\">D &amp; E are correct</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasonographic criteria for the diagnosis of PCOD include?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Number of follicles/ovaries </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian volume </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal volume </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal echogenicity </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal blood flow</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q4168477",
      "question_audio": null,
      "question_video": null,
      "map_id": 18845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. A &amp; B are correct</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the consensus definition, polycystic ovaries are present when:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One or both ovaries demonstrate 12 or more follicles measuring 2-9 mm in diameter <strong>and/or</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The ovarian volume exceeds 10 cm<sup>3</sup>. </span></span></span></span></li>\r\n</ol>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only one ovary meeting either of these criteria is sufficient to establish the presence of polycystic ovaries </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal Echogenicity and Volume have been described, but do not contribute to formal diagnostic criteria. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal blood flow is not included in ultrasonographic diagnostic criteria for PCOD</span></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Updated Ultrasonographic criteria for the diagnosis of PCOD by ESHRE guidelines 2018</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovaries may be normal in PCOS, and conversely, polycystic ovarian morphology (PCOM) may be seen in women without the syndrome. However, it is well accepted that women with PCOS tend to have larger ovaries with an increased number of follicles. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The updated diagnostic criteria at the time of review are based on a 2018 International consensus guideline (ESHRE guideline)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients &gt; 8 years post menarche, and using a high-frequency endo-vaginal probe &nbsp;(8MHz)</span></span></span></span>\r\n\t<ol style=\"list-style-type:lower-roman\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicle number per ovary (FNPO) &ge; 20, and/or </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian volume &ge;10 mL, ensuring no corpora lutea, cysts or dominant follicles are present </span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If using transabdominal scanning, or older technology where ovarian morphology is not well visualized, consider using the ovarian volume threshold of &ge;10 ml on either ovary. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnostic criteria are adjusted in adolescent females (defined as within 8 years of menarche, or age &lt;20 years), in whom ultrasound should not be used for the diagnosis of PCOS due to the high incidence of multi-follicular ovaries in this life stage. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This supersedes the initial Rotterdam criteria of &ge; 12 follicles. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of a single multi-follicular ovary is sufficient to provide the sonographic criterion for PCOS </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other morphological features have been described, but do not contribute to formal diagnostic criteria:</span></span></span></span>\r\n\t<ol style=\"list-style-type:lower-roman\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal Echogenicity and Volume (hyperechoic central stroma) </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral location of follicles (string of pearls sign) </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicles of similar size measuring 2-9 mm </span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Number of Follicles/Ovaries</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. One of the criteria for PCOS on ultrasound is the presence of a high number of follicles in the ovaries. According to the Rotterdam criteria, this is typically defined as 12 or more follicles measuring 2-9 mm in diameter in each ovary.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian Volume</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Another ultrasonographic criterion for PCOS is increased ovarian volume. The Rotterdam criteria define this as an ovarian volume greater than 10 cm&sup3;.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Stromal Volume</strong>: While stromal volume may be increased in PCOS, it is not a specific criterion for the diagnosis on ultrasound. The diagnosis is more commonly based on the number of follicles and ovarian volume.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stromal Echogenicity</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Increased stromal echogenicity can be seen in PCOS, but it is not part of the standard criteria fordiagnosis on ultrasound.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. E.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Stromal Blood Flow</strong>: Changes in stromal blood flow may occur in PCOS; however, it is not a defined criterion for its diagnosis in ultrasonography.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct answer is <strong>B)&nbsp;A &amp; B are correct</strong>, as the number of follicles per ovary and ovarian volume are key ultrasonographic criteria for diagnosing PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The ultrasonographic criteria for diagnosing PCOS include the presence of 12 or more follicles measuring 2-9 mm in diameter per ovary and/or increased ovarian volume (&gt;10 cm&sup3;). These criteria are part of the Rotterdam criteria for the diagnosis of PCOS and are essential in the assessment of this condition</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 401, Speroff&rsquo;s clinical gynecological endocrinology and infertility 9<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12160,
      "choices": [
        {
          "id": 48604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">TSH</span></span></span></span></p>"
        },
        {
          "id": 48605,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">LH</span></span></span></span></p>"
        },
        {
          "id": 48606,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Urinary ketosteroids</span></span></span></span></p>"
        },
        {
          "id": 48607,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HCG</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In galactorrhea-amenorrhea syndrome, the investigation you should advise apart from serum prolactin levels is? </span></span></span></span></p>",
      "unique_key": "Q7254386",
      "question_audio": null,
      "question_video": null,
      "map_id": 18846,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. TSH</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperprolactinemia leads to both galactorrhea and amenorrhea. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactin secretion is controlled by a prolactin inhibitor factor that is secreted from the hypothalamus.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other factors like vasoactive inhibitory peptide (VIP) and thyroid releasing hormone (TRH) cause increased prolactin secretion. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In fact, TRH in addition to increasing TSH causes a rise in prolactin levels. In patients with galactorrhea-amenorrhea S.TSH should be evaluated. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperprolactinemia leads to both galactorrhea and amenorrhea. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 401, Speroff&rsquo;s Clinical Gynecological Endocrinology, and Infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12161,
      "choices": [
        {
          "id": 48608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elevated LH, ratio of LH/FSH is &gt; 3:1</span></span></span></span></p>"
        },
        {
          "id": 48609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reversible estradiol: estrone ratio</span></span></span></span></p>"
        },
        {
          "id": 48610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reduced SHBG level.</span></span></span></span></p>"
        },
        {
          "id": 48611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reduced serum insulin level.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following serum values is NOT in favour of diagnosis of PCOS? </span></span></p>",
      "unique_key": "Q3927797",
      "question_audio": null,
      "question_video": null,
      "map_id": 18847,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Reduced serum insulin level</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH level is elevated and/or ratio of LH: FSH is &gt; 3:1</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversed estradiol: estrone ratio- The estrone level is markedly elevated.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHBG level is reduced.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androstenedione level is elevated.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum testosterone and DHEA may be marginally elevated. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised serum insulin level </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ratio of fasting glucose: fasting insulin is &lt; 4.5</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us review each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated LH, Ratio of LH/FSH is &gt; 3:1</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Elevated LH and a high LH/FSH ratio are common findings in PCOS. An elevated ratio often reflects the altered hormonal environment characteristic of PCOS </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversible Estradiol: Estrone Ratio</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In PCOS, there can be an altered ratio of estradiol to estrone. This change is due to increased peripheral conversion of androgens to estrogens, particularly in adipose tissue. While this change can be seen in PCOS, it&#39;s not as specific or diagnostic as other hormonal alterations.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reduced SHBG Level</strong>: Reduced levels of sex hormone-binding globulin (SHBG) are a typical finding in PCOS. Lower SHBG leads to higher levels of free androgens, contributing to the hyperandrogenism seen in PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced Serum Insulin Level</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct as the exception. PCOS is often associated with insulin resistance, which typically leads to elevated, not reduced, insulin levels. Reduced serum insulin levels would not typically support a diagnosis of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In diagnosing PCOS, typical hormonal findings include elevated LH levels, a high LH/FSH ratio, reduced SHBG levels, and often elevated insulin levels due to insulin resistance. Reduced serum insulin levels are not characteristic of PCOS and would not support its diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 419, Speroff&rsquo;s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12163,
      "choices": [
        {
          "id": 48616,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Clomiphene citrate</span></span></p>"
        },
        {
          "id": 48617,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cyclical progesterone tablets</span></span></p>"
        },
        {
          "id": 48618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">OC pills containing levonorgestrel</span></span></p>"
        },
        {
          "id": 48619,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">OC pills containing cyproterone acetate</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19-year-old unmarried girl presents with irregular periods, acne and facial hair. The best treatment for her is?</span></span></span></span></p>",
      "unique_key": "Q4112723",
      "question_audio": null,
      "question_video": null,
      "map_id": 18848,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. OC pills containing cyproterone</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS is a heterogeneous syndrome complex characterized by chronic anovulation with androgen excess and frequently associated with insulin resistance, resulting in menstrual irregularity, infertility, acne and hirsutism.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills are the first-line therapy drug of choice for PCOS patients with menstrual abnormalities and hirsutism, acne (Not wanting fertility)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC pills will make the menstrual cycles regular and suppress acne and hirsutism.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyproterone is a progesterone with anti-androgenic properties and hence it is best for those patients who have androgen excess.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclical progesterone treatment will only regularize the cycles and will not help in treatment of acne and hirsutism.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us consider the best treatment options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphene Citrate</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Clomiphene citrate is primarily used for ovulation induction in women with infertility, particularly in those with polycystic ovary syndrome (PCOS). It is not the best choice for treating acne and hirsutism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclical Progesterone Tablets</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cyclical progesterone can be used to regulate menstrual cycles in cases of anovulation or irregular periods. However, it doesn&#39;t directly address hyperandrogenism symptoms such as acne and facial hair.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>OC Pills Containing Levonorgestrel</strong>: Oral contraceptives containing levonorgestrel can regularize menstrual cycles and provide contraception. However, levonorgestrel is a more androgenic progestin and might not be the best choice for treating acne and hirsutism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC Pills Containing Cyproterone Acetate</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct. Oral contraceptive pills containing cyproterone acetate are effective in treating symptoms of hyperandrogenism such as acne and hirsutism, in addition to regulating menstrual cycles. Cyproterone acetate has anti-androgenic properties, making it particularly suitable for these symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In young women with symptoms of hyperandrogenism (such as acne and hirsutism) and irregular periods, oral contraceptive pills containing anti-androgenic progestins like cyproterone acetate are often the best treatment option. These pills help regulate menstrual cycles and directly address androgen-related symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 423, Speroff&rsquo;s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48619,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12164,
      "choices": [
        {
          "id": 48620,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphene citrate </span></span></span></span></p>"
        },
        {
          "id": 48621,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal acetate</span></span></span></span></p>"
        },
        {
          "id": 48622,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian drilling </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>"
        },
        {
          "id": 48623,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Letrozole</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a treatment option for PCOS?</span></span></p>",
      "unique_key": "Q5268081",
      "question_audio": null,
      "question_video": null,
      "map_id": 18849,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Ulipristal acetate</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovary syndrome</span></span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A diagnosis of PCOS must meet 2 out of 3 criteria (Rotterdam Criteria)</span></span></span></span>\r\n\t<ol>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Androgen excess with clinical hyperandrogenism or elevated serum free or total testosterone</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian dysfunction with oligo/ anovulation </span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovary morphology on ultrasound</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle Modifications</span></span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the patient wishes to become pregnant (Desirous of fertility)</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Letrozole: 1<sup>st</sup> line drug for ovulation induction</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphene can also be used for ovarian stimulation.</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin can improve menstruation but has little or no benefit in treating infertility; it is beneficial for metabolic or glucose abnormalities.</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2<sup>nd</sup> line: gonadotropins and Laparoscopic ovarian drilling</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the patient does not desire pregnancy: </span></span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Combined OCP</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medroxyprogesterone acetate, 10 mg daily orally for the latter half of the cycle (Day 15-25)</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The levonorgestrel-containing IUD is another option to minimize uterine bleeding and protect against endometrial hyperplasia.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A low-dose combination oral contraceptive (progesterone component of the pill should preferably be cyproterone acetate or Drospirenone) for at least 6&ndash;12 months.</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spironolactone is also useful in doses of 25 mg three or four times daily orally.</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flutamide, 125&ndash;250 mg once daily orally, and finasteride, 5 mg once daily orally, are also effective</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Because spironolactone, flutamide, and finasteride are potentially teratogenic, they should only be used with secure contraception.</span></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical eflornithine cream applied to affected facial areas twice daily for 6 months may be helpful.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">let&#39;s summarize each option:</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphene Citrate</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Used for Induction of ovulation in women with PCOS, particularly those who are experiencing infertility. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal Acetate</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct as the exception. Ulipristal acetate is used as an emergency contraceptive and for the treatment of uterine fibroids. It is not a treatment option for PCOS, which requires management of symptoms like irregular menstrual cycles, hyperandrogenism, and insulin resistance.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ovarian Drilling</strong>: Ovarian drilling used particularly in women who do not respond to ovulation-inducing medications. It can help to restore ovulation by reducing ovarian androgen production.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. D.</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Letrozole</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Letrozole is used in the treatment of PCOS for ovulation induction, especially in women who are trying to conceive. It has been found to be effective in inducing ovulation and improving pregnancy rates in women with PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In the management of PCOS, common treatments include clomiphene citrate and letrozole for ovulation induction and ovarian drilling as a surgical option for those not responding to medication. Ulipristal acetate, used for emergency contraception and uterine fibroids, is not a treatment option for PCOS</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 424, Speroff&rsquo;s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12165,
      "choices": [
        {
          "id": 48624,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Letrozole</span></p>"
        },
        {
          "id": 48625,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Clomiphene citrate</span></p>"
        },
        {
          "id": 48626,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Metformin</span></p>"
        },
        {
          "id": 48627,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Oral contraceptive pills</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25-year-old lady with infertility, irregular menstrual cycles, and hirsutism, is diagnosed to have polycystic ovarian syndrome. All of the following are treatment options in this patient except:</span></p>",
      "unique_key": "Q8307930",
      "question_audio": null,
      "question_video": null,
      "map_id": 18850,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D. OCPs</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">PCOS can be managed in women desirous of fertility with ovulation induction drugs</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">These include</span></p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Letrozole (drug of choice)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Clomiphene citrate</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gonadotropins</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Other drugs like tamoxifen also have been used to cause ovulation induction in women with PCOS</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Metformin alone or in combination with clomiphene citrate helps induce ovulation especially in women with high insulin resistance</span></p></li></ol></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>OCPs can be given to women with PCOS with irregular cycle who ARE NOT desirous of fertility.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Since this woman has infertility, OCPs should be the answer.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at the other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:transparent;font-size:16px;\"><strong>Option A. Letrozole:</strong> it is the drug od choice for ovulation induction in PCOS.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option. B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Clomiphene Citrate</strong>: Clomiphene citrate is a common first-line treatment for infertility in PCOS. It induces ovulation by blocking estrogen receptors, leading to increased FSH and LH production.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Metformin</strong>: Metformin is used in PCOS, especially in patients with insulin resistance. It can improve menstrual regularity and ovulation, and it is beneficial for metabolic aspects of PCOS.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In treating PCOS, clomiphene citrate and metformin are common options, especially when addressing infertility. OCPs are used for managing menstrual irregularities and hyperandrogenism but are not suitable for treating infertility due to their contraceptive nature. Tamoxifen is not typically used in PCOS treatment but can be used for ovulation induction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Page 424, Speroff’s Clinical Gynecological Endocrinology and Infertility 9<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 48627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}